Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

This study has been completed.

Study NCT00060125 Information provided by Cancer and Leukemia Group B

First Received: May 6, 2003 Last Updated: March 31, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	February 2008
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)

Publications:

Gajewski TF, Niedzwiecki D, Johnson J, et al.: Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104. [Abstract] J Clin Oncol 24 (Suppl 18): A-8014, 456s, 2006.